Drug Profile
Iobenguane I-131 - FUJIFILM Toyama Chemical
Alternative Names: 3-iodobenzylguanidine (I-131); 131I-MIBG - FUJIFILM Toyama Chemical; F-1614; I-131 3-iodobenzylguanidine; Raiatt MIBG-I 131Latest Information Update: 11 Oct 2021
Price :
$50
*
At a glance
- Originator FUJIFILM RI Pharma
- Developer FUJIFILM Toyama Chemical
- Class Antineoplastics; Guanidines; Imaging agents; Iodobenzenes; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules; Sulfates
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Phaeochromocytoma
- Discontinued Neuroblastoma
Most Recent Events
- 11 Oct 2021 Discontinued - Preclinical for Neuroblastoma in Japan (IV)
- 27 Sep 2021 Registered for Phaeochromocytoma in Japan (IV) (FUJIFILM Toyama Chemical pipeline, September 2021)
- 28 Dec 2020 No recent reports of development identified for preclinical development in Neuroblastoma in Japan (IV, Infusion)